UP!

OCRX $1.79

OCRX target price
1.79
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-04-12 Reiterated Rating Brean Capital Buy
2016-03-06 Reiterated Rating Cowen and Company Buy $11.00
2016-03-06 Reiterated Rating Brean Capital Buy $10.00
2016-02-23 Initiated Coverage Brean Capital Buy $10.00
2015-11-06 Boost Price Target Cowen and Company $10.00 to $11.00
2015-03-12 Lower Price Target Stifel Nicolaus Buy $17.00 to $15.00
2014-08-12 Lower Price Target Stifel Nicolaus Buy $19.00 to $17.00
2014-06-11 Initiated Coverage JMP Securities Market Perform to Outperform $15.00
2014-01-06 Upgrade BMO Capital Markets Market Perform to Outperform $8.00 to $26.00
2013-12-30 Initiated Stifel Buy $19
2013-12-30 Initiated Coverage Stifel Nicolaus Hold to Buy $19.00
2013-12-17 Initiated Coverage Cowen and Company Outperform
2016-04-12 Reiterated Rating Brean Capital Buy
2016-03-06 Reiterated Rating Cowen and Company Buy $11.00
2016-03-06 Reiterated Rating Brean Capital Buy $10.00
2016-02-23 Initiated Coverage Brean Capital Buy $10.00
2015-11-06 Boost Price Target Cowen and Company $10.00 to $11.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In OCRX 4 funds of 2213 total. Show all

Fund name Ticker shares
VHCP Management, LLC 0.91M
KCG Holdings, Inc. 0.21M
BlackRock Fund Advisors 56990
BlackRock Investment Management, LLC 2764

Major Shareholders

Name Relationship Total Shares Holding stocks
Baker Brothers Life Sciences Capital (GP), LLC 17.93%  (3540015) HRTX / OCRX /
H.I.G. Ventures - Tranzyme, LLC 15.21%  (3002291) OCRX /
QUAKER BIO VENTURES LP 12.99%  (2564791) CPXX / OCRX / RGDO /
Zisson Alex 12.66%  (2500002) ASPX / CPXX / OCRX /
BDC CAPITAL INC. 11.34%  (2238825) OCRX /
VITULLO NICOLE 9.41%  (1857036) ACHN / AKAO / CADX / CLVS / CPXX / DRNA / DRTX / ESPR / EVOK / MRNS / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
TREU JESSE I 9.41%  (1857036) ACHN / AKAO / ALDX / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
DOVEY BRIAN H 9.41%  (1857036) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / OTIC / RGDO / TNDM / VCYT / ZGNX /
SCHOEMAKER KATHLEEN K 9.41%  (1857036) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
BLAIR JAMES C 9.41%  (1857036) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
Thomas, McNerney & Partners II L.P. 8.87%  (1751393) ASPX / CASM / OCRX /
Capital regional et cooperatif Desjardins 6.39%  (1262022) OCRX /
THOMAS MCNERNEY & PARTNERS LP 3.86%  (762892) OCRX / ZGNX /
Baker Biotech Capital (GP), LLC 1.18%  (232011) HRTX / OCRX /
14159 capital (GP), LLC 0.29%  (57704) HRTX / OCRX /
Aggarwal Gaurav Chief Business Officer 0.10%  (20000) HPTX / OCRX /
POWELL MICHAEL 0.07%  (14328) OCRX / OREX / SYBX /
SOFINNOVA VENTURE PARTNERS VI L P 0.05%  (9364) ANTH / OCRX /
Halak Brian K 0.04%  (7333) ACHN / AKAO / ALIM / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / TNDM / VCYT / VNDA / ZGNX /
Patni Rajiv Chief Development Officer 0.03%  (5050) ADMS / OCRX /
TETLOW SHARON Acting CFO & Treasurer 0.02%  (3000) OCRX /
Moore David VP, Commercial Operations 0.01%  (1050) CEMP / OCRX /